BIODELIVERY SCIENCES INTERNATIONAL INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenues:
Product sales
Product royalty revenues
Research and development reimbursements
Contract revenue
Total revenues
Cost of sales
Revenues
Product sales, net
Product royalty revenues
Research And Development Reimbursements
Contract revenue
Total revenues
Cost of sales
Expenses:
Research and development
Selling, general and administrative
Total expenses
Income from operations
Bargain purchase gain
Interest expense, net of interest income
Other (expense) income, net
Income (loss) before taxes
Income tax benefit (expense)
Net income (loss)
Beneficial conversion feature of convertible preferred stock
Net income (loss) attributable to common stockholders
Basic:
Weighted average common stock shares outstanding (in shares)
Basic income (loss) per share (in dollars per share)
Diluted:
Diluted weighted average common stock shares outstanding (in shares)
Diluted income (loss) per share (in dollars per share)

Comments